Literature DB >> 26522098

Temporary prophylactic intravascular balloon occlusion of the common iliac arteries before cesarean hysterectomy for controlling operative blood loss in abnormal placentation.

Min Min Chou1, Hsiao Fan Kung2, Jen I Hwang3, Wei Chi Chen4, Jenn Jhy Tseng4.   

Abstract

OBJECTIVES: The purpose of this study was to investigate the efficacy and safety of temporary prophylactic intravascular balloon occlusion of the common iliac arteries (CIA) before planned cesarean hysterectomy for controlling operative blood loss in abnormal placentation.
MATERIALS AND METHODS: A retrospective study of 13 pregnant women at risk for placenta accreta identified using sequential obstetric ultrasonography and magnetic resonance imaging from January 2007 to December 2009 was performed. Temporary prophylactic intravascular balloon catheterization of the bilateral CIA before cesarean hysterectomy was performed by interventional radiologists. The maximum duration of occlusion time of CIA must not exceed 60 minutes. The primary outcome for this study included estimated blood loss and secondary outcomes included the development of thromboembolism, disseminated intravascular coagulation and surgical complications.
RESULTS: Among these 13 patients, the mean age of the patients was 32.8 ± 0.7 years (range 29-37 years). The mean gestational age at cesarean hysterectomy was 32.2 ± 0.9 weeks (range 28-36 weeks), and the mean intraoperative blood loss was 1902.3 ± 578.8 mL (range 500-8000 mL). Operative bleeding was controlled by conservative treatment without additional surgery in two cases. Importantly, two patients (15.8%) had severe complications possibly related to the interventional procedure. One patient was noted to have a popliteal artery thrombosis. A second patient had an external iliac artery thrombosis with 80-90% occlusion. Both patients required antithrombotic treatment without sequelae.
CONCLUSION: With limited experience in this small series, we observed a statistically significant reduction in operative blood loss after the use of temporary prophylactic balloon occlusion of the CIA technique compared with historical controls of similar demographic characteristics previously published (1902.3 ± 578.8 mL, range 500-8000 mL vs. 4445.7 ± 996.48 mL, range 1040-15,000 mL, p = 0.0402). Additionally, two patients had arterial thrombosis. These preliminary findings are based on a small number of patients, and therefore further investigation is needed to determine the effectiveness and safety of this new technique.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  abnormal placentation; arterial thrombosis; balloon occlusion; cesarean hysterectomy; common iliac arteries

Mesh:

Year:  2015        PMID: 26522098     DOI: 10.1016/j.tjog.2014.03.013

Source DB:  PubMed          Journal:  Taiwan J Obstet Gynecol        ISSN: 1028-4559            Impact factor:   1.705


  9 in total

Review 1.  Endovascular interventional modalities for haemorrhage control in abnormal placental implantation deliveries: a systematic review and meta-analysis.

Authors:  Yousef Shahin; Chun Lap Pang
Journal:  Eur Radiol       Date:  2018-02-05       Impact factor: 5.315

2.  Vascular complications following prophylactic balloon occlusion of the internal iliac arteries resolved by successful interventional thrombolysis in a patient with morbidly adherent placenta.

Authors:  Ning Zhang; Wei-Hua Lou; Xue-Bin Zhang; Jia-Ning Fu; Yun-Yan Chen; Zhi-Guo Zhuang; Jian-Hua Lin
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

Review 3.  The role of interventional radiology in the management of abnormally invasive placenta: a systematic review of current evidences.

Authors:  Philippe Soyer; Maxime Barat; Romaric Loffroy; Matthias Barral; Raphael Dautry; Vincent Vidal; Olivier Pellerin; Francois Cornelis; Maureen P Kohi; Anthony Dohan
Journal:  Quant Imaging Med Surg       Date:  2020-06

Review 4.  Expanding the field of acute care surgery: a systematic review of the use of resuscitative endovascular balloon occlusion of the aorta (REBOA) in cases of morbidly adherent placenta.

Authors:  R Manzano-Nunez; M F Escobar-Vidarte; M P Naranjo; F Rodriguez; P Ferrada; J D Casallas; C A Ordoñez
Journal:  Eur J Trauma Emerg Surg       Date:  2017-09-19       Impact factor: 3.693

5.  Prophylactic balloon occlusion of internal iliac arteries, common iliac arteries and infrarenal abdominal aorta in pregnancies complicated by placenta accreta: a retrospective cohort study.

Authors:  Kui Li; Yu Zou; Jin Sun; Hong Wen
Journal:  Eur Radiol       Date:  2018-06-05       Impact factor: 5.315

6.  Factors Contributing to Massive Blood Loss on Peripartum Hysterectomy for Abnormally Invasive Placenta: Who Bleeds More?

Authors:  Hironori Takahashi; Akihide Ohkuchi; Rie Usui; Hirotada Suzuki; Yosuke Baba; Shigeki Matsubara
Journal:  Obstet Gynecol Int       Date:  2016-08-17

7.  Study of the utility and problems of common iliac artery balloon occlusion for placenta previa with accreta.

Authors:  Yoshihisa Ono; Yoshihiko Murayama; Sumiko Era; Shigetaka Matsunaga; Tomonori Nagai; Hisato Osada; Yasushi Takai; Kazunori Baba; Satoru Takeda; Hiroyuki Seki
Journal:  J Obstet Gynaecol Res       Date:  2018-01-03       Impact factor: 1.730

8.  A prospective observational study evaluating the efficacy of prophylactic internal iliac artery balloon catheterization in the management of placenta previa-accreta: A STROBE compliant article.

Authors:  Yao Fan; Xun Gong; Nan Wang; Ketao Mu; Ling Feng; Fuyuan Qiao; Suhua Chen; Wanjiang Zeng; Haiyi Liu; Yuanyuan Wu; Qiong Zhou; Yuan Tian; Qiang Li; Meitao Yang; Fanfan Li; Mengzhou He; Rajluxmee Beejadhursing; Dongrui Deng
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

9.  The effect prophylactic internal iliac artery balloon occlusion in patients with placenta previa or placental accreta spectrum: a systematic review and meta-analysis.

Authors:  Anisodowleh Nankali; Nader Salari; Mohsen Kazeminia; Masoud Mohammadi; Samira Rasoulinya; Melika Hosseinian-Far
Journal:  Reprod Biol Endocrinol       Date:  2021-03-04       Impact factor: 5.211

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.